Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: Suppression by interleukin 10

British Journal of Cancer

Volumn 77, Issue 9, 1998, Pages 1413-1419

  Dummer, R ^a   Yue, F Y ^a   Pavlovic, J ^a   Geertsen, R ^a   Dohring C ^b   Moelling, K ^a   Burg, G ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

B7.1 (CD80); B7.2 (CD86); Gene therapy; Interferon gamma; Interleukin 10; Interleukin 2; Interleukin 4; Melanoma; Retroviral gene transfer; T cell response; Transduction

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MELANOMA CELL; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0031942907     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.234     Document Type: Article

References (38)

1. Altschul S, Gish W, Miller W, Myers E and Lipman D (1990) Basic local alignment search tool. J Mol Biol 215: 403-410
2. Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ and Figdor CG (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179: 1005-1009
3. Becker JC, Brabletz T, Czerny C, Termeer C and Brocker EB (1993a) Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma. Int Immunol 5: 1501-1508
4. Becker JC, Schwinn A, Dummer R, Burg G and Brocker EB (1993b) Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production. J Invest Dermatol 101: 15-21
5. Becker JC, Czerny C and Brocker EB (1994) Maintenance of clonal anergy by endogenously produced IL- 10. Int Immunol 6: 1605-1612
6. Brodsky FM and Parham P (1982) Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol 128: 129-135
7. Butch AW, Chung GH, Hoffmann JW and Nahm MH (1993) Cytokine expression by germinal center cells. J Immunol 150: 39-47
8. Bystryn JC (1989) Immunosurveillance and melanoma. J Invest Dermatol 92: S318-320
9. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL and Banchereau J (1994) B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 180: 1841-1847
10. Chen Q, Daniel V, Maher DW and Hersey P (1994) Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 56: 755-760
11. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schopf E and Simon JC (1995) In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Int J Cancer 62: 259-265
12. deWaal Malefyt R, Yssel H and de VJ (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150: 4754-4765
13. Döhring C, Angman L, Spagnoli G and Lanzavecchia A (1944) T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int J Cancer 57: 754-759
14. Dummer R and Boni R (1995) Wie entkommen Melanomzellen der Immunantwort? Konsequenzen fur zukunftige Therapieansatze und gegenwartige Biopsieverarbeitung. Schweiz: Med Wochenschr 125: 1638-1641
15. Dummer R, Heald PW, Nestle FO, Ludwig E, Laine E, Hemmi S and Burg G, (1996) Sézary syndrome's T-cell clones display T helper 2 cytokines and express the accessory factor-1 (interferon gamma receptor beta chain). Blood 88: 1383-1389
16. Fenton RT, Sznol M, Luster DG, Taub DD and Longo DL (1995) A phase I trial of B7-transfected parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401. Hum Gene Ther 6: 87-106
17. Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG and Nadler LM (1991) Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 174: 625-631
18. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VJ, Lombard LA, Gray GS and Nadler LM (1993) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation (see comments). Science 262: 909-911
19. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert P D, Gray GS, Gribben JG and Nadler LM (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2: 523-532
20. Gajewski TF, Fallarino F, Uyttenhove C and Boon T (1996) Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor-superiority of B7-1 over B7-2 for active tumor immunization. J Immunol 156: 2909-2917
21. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ and Nadler LM (1994) Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84: 3261-3282
22. Howard M and O'Garra A (1992) Biological properties of interleukin 10. Immunol Today 13: 198-200
23. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E and Rosenberg SA (1944) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180: 347-352
24. Kruger-Krasagakes S, Krasagakis K, Garbe C and Diamantstein T (1995) Production of cytokines by human melanoma cells and melanocytes. Recent Results Cancer Res 139: 155-168
25. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N and Glimcher LH (1995) B7-I and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718
26. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D and Azuma M (1995) CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154: 97-105
27. Li Y, McGowan P, Hellstrom I, Hellstrom KE and Chen L (1994) Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J Immunol 153: 421-428
28. Markowitz D, Goff S, and Bank A (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62: 1120-1124
29. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG and Kiessling R (1994) Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180: 2371-2376
30. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G and Herlyn M (1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56: 853-857
31. Miller AD and Rosman GJ (1984) Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980-990
32. Reilly PL, Woska JR Jr, Jeanfavre DD, McNally E, Rothlein R and Bormann BJ (1995) The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J Immunol 155: 529-532
33. Robbins PA, Evans EL, Ding AH, Warner NL and Brodsky FM (1987) Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. Hum Immunol 18: 301-313
34. Sule-Suso J, Arienti F, Melani C, Colombo MP and Parmiani G (1995) A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogencic lymphocytes. Eur J Immunol 25: 2737-2742
35. Townsend SE and Allison JP (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259: 368-370
36. Valle A, Garrone P, Yssel H, Bonnefoy JY, Freedman AS, Freeman G, Nadler LM and Banchereau J (1990) mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology 69: 531-535
37. Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, deVries JE, Roncarolo MG, Mosmann TR and Moore KW (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88: 1172-1176
38. Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S and Rosenberg SA (1993) Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. Cancer Res 53: 5-8